Five Years Follow-up of Opsoclonus-Myoclonus-Ataxia Syndrome-Associated Neurogenic Tumors in Children.
Elif Habibe AktekinHasan Özkan GezerNalan Yazıcıİlknur ErolAyşe ErbayFaik SarıalioğluPublished in: Neuropediatrics (2023)
In tumor-related cases, alternating use of corticosteroid and IVIG for suppression of autoimmunity as the OMAS protocol, total excision of the tumor as soon as possible, and chemotherapeutics in selected patients seem to be related to resolution of acute problems, long-term sequelae, and severity.